An interlaboratory comparison of enhanced morphological transformation of Syrian hamster embryo cells cultured under conditions of reduced bicarbonate concentration and pH.
Initial studies performed in our laboratory indicated that early passage Syrian hamster embryo (SHE) cells exhibit optimal clonal proliferation when cultured in medium with a sodium bicarbonate concentration of 8.9 mM and pH of 6.70 instead of 44 mM and pH 7.35 as used previously by others. Subsequent studies indicated that morphological transformation frequency induced by benzo[a]pyrene (BP) was also enhanced at pH 6.70 compared to 7.35 and the level of enhancement was affected by cell density and duration of culture. With optimal conditions identified, the carcinogens BP, 3-methylcholanthrene, N-methyl-N'-nitro-N-nitrosoguanidine, 2-acetylaminofluorene and the non-carcinogen anthracene were tested at pH 6.70 and 7.35 in our laboratory and at Microbiological Assoc. Inc. under code. Additionally, the non-carcinogens 4-acetylaminofluorene, and caprolactam were tested in our laboratory. Results from these studies indicate that all carcinogens tested caused a significant increase in morphological transformation frequency compared to controls at pH 6.70. In contrast, only BP caused a significant increase in the morphological transformation frequency at pH 7.35. The non-carcinogens did not significantly increase the morphological transformation frequency compared to controls. Interlaboratory comparisons were in qualitative agreement despite the fact that different lots of serum and hamster cell isolates were used by the two laboratories. However, different dose-response curves for the various chemicals were observed between the two labs. It was also demonstrated that the enhanced morphological transformation frequency is not due to a decrease in culture medium osmolality or Na concentration, a condition which accompanies media with a reduced bicarbonate concentration and pH. These results demonstrate that the chemicals tested, low pH transformation of SHE cells agrees with carcinogenic potential and that assay variability is minimized. The implications of these results regarding use of the SHE cell assay as a short-term test for predicting the carcinogenic potential of chemicals are discussed.
LeBoeuf
R A
RA
Procter and Gamble Company, Human and Environmental Safety Division, Cincinnati, OH 45247.
Kerckaert
G A
GA
Poiley
J A
JA
Raineri
R
R
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism*; D015197:Carcinogenicity Tests / Q000379:methods; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D002999:Clone Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D006224:Cricetinae; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian; D006863:Hydrogen-Ion Concentration; D008647:Mesocricetus; D009994:Osmolar Concentration; D012964:Sodium / Q000378:metabolism*; D017693:Sodium Bicarbonate
D001639:Bicarbonates; D003470:Culture Media; D017693:Sodium Bicarbonate; D012964:Sodium